智擎 (4162)
智擎 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$223.44M, up 13.1% from a year earlier. EPS over the last four quarters totals NT$3.75.
Company profile
Data as of 2026-10-14
- Market
- TPEx-listed
- Industry
- Biotech & Medical Care
- Listed
- 2012-09-18
- Founded
- 2002-08-12
- Paid-in capital
- NT$1.44B
- Common shares issued
- 143,677,640
- Legal name
- 智擎生技製藥股份有限公司
- Website
- https://www.pharmaengine.com
Monthly revenue
Data as of 2026-10-15
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$223.44M | +982.1% | +13.1% |
| 2026-08 | NT$20.65M | -11.5% | -7.0% |
Year to date: +22.2% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | 0.93 |
| 2026 Q1 | 0.96 |
| 2025 Q4 | 0.91 |
| 2025 Q3 | 0.95 |
| 2025 Q2 | 0.13 |
| 2025 Q1 | 0.71 |
| 2024 Q4 | 9.87 |
| 2024 Q3 | 0.64 |
Last four quarters: NT$3.75
Dividends
Data as of 2026-10-14
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 2.00 | 0.00 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 34,509 | 0.5% |
| 1,000–5,000 shares | 9,785 | 13.7% |
| 5,001–10,000 shares | 1,318 | 7.0% |
| 10,001–15,000 shares | 442 | 3.9% |
| 15,001–20,000 shares | 215 | 2.7% |
| 20,001–30,000 shares | 238 | 4.2% |
| 30,001–40,000 shares | 124 | 3.1% |
| 40,001–50,000 shares | 59 | 1.9% |
| 50,001–100,000 shares | 133 | 6.4% |
| 100,001–200,000 shares | 51 | 5.2% |
| 200,001–400,000 shares | 29 | 5.8% |
| 400,001–600,000 shares | 8 | 2.8% |
| 600,001–800,000 shares | 4 | 1.8% |
| 800,001–1,000,000 shares | 4 | 2.6% |
| 1,000,001+ shares | 7 | 38.3% |
TDCC data for 2026-10-16: 7 holders own more than 1,000 lots (38.3% of shares), and 34,509 hold less than one lot (0.5%).
Institutional net buying (last 20 trading days)
Data as of 2026-10-19
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-10-19 | -39 | 0 | -1 | -40 |
| 2026-10-16 | 92 | 0 | 12 | 104 |
| 2026-10-15 | 133 | 0 | -12 | 121 |
| 2026-10-14 | -4 | 0 | -1 | -5 |
| 2026-10-13 | -46 | 0 | 16 | -30 |
| 2026-10-12 | -15 | 0 | 0 | -15 |
| 2026-10-08 | -121 | 0 | 0 | -121 |
| 2026-10-07 | 25 | 0 | 0 | 25 |
| 2026-10-06 | 22 | 0 | 0 | 22 |
| 2026-10-05 | -59 | 0 | -2 | -61 |
| 2026-10-02 | -7 | 0 | 0 | -7 |
| 2026-10-01 | -55 | 0 | -3 | -58 |
| 2026-09-30 | 56 | 0 | 0 | 56 |
| 2026-09-29 | -33 | 0 | -1 | -34 |
| 2026-09-24 | -76 | 0 | 0 | -76 |
| 2026-09-23 | 92 | 0 | 2 | 94 |
| 2026-09-22 | 62 | 0 | 2 | 64 |
| 2026-09-21 | -10 | 0 | 4 | -6 |
| 2026-09-18 | -42 | 0 | -1 | -43 |
| 2026-09-17 | 169 | 0 | 6 | 175 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net buyers of 165 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$56.80 (2026-10-19); 52-week range NT$53.00–74.40.
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.